Michael D Belbis, Michael J Holmes, Joseph Yao, Christopher W Kinnick, Christopher K Kargl, Carly Day, Nicole L Noel, Timothy P Gavin, Bruno T Roseguini, Daniel M Hirai
{"title":"Effects of acute selective cyclooxygenase-2 inhibition on skeletal muscle microvascular oxygenation and exercise tolerance.","authors":"Michael D Belbis, Michael J Holmes, Joseph Yao, Christopher W Kinnick, Christopher K Kargl, Carly Day, Nicole L Noel, Timothy P Gavin, Bruno T Roseguini, Daniel M Hirai","doi":"10.1113/EP092518","DOIUrl":null,"url":null,"abstract":"<p><p>The cyclooxygenase (COX) pathway regulates vascular tone and, therefore, local O<sub>2</sub> delivery-utilization matching. The two main isoforms, COX-1 and COX-2, may promote opposing effects on contracting muscle O<sub>2</sub> transport in health by inducing vasoconstriction and vasodilatation, respectively. Whether COX-2 and its main vasodilatory product (prostacyclin, PGI<sub>2</sub>) modulate microvascular O<sub>2</sub> transport to skeletal muscle and thus exercise tolerance is unknown. We tested the hypothesis that acute selective COX-2 inhibition (SC2I) would impair cardiorespiratory and skeletal muscle microvascular responses from rest to exercise, thereby reducing exercise tolerance in healthy adults. Twelve individuals participated in a randomized, double-blind, crossover study to receive SC2I (200 mg celecoxib) or placebo (control, CON). Moderate and severe intensity cycling were performed with measurements of heart rate, arterial blood pressure, pulmonary oxygen uptake ( <math> <semantics> <msub><mover><mi>V</mi> <mo>̇</mo></mover> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${\\dot V_{{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> ), leg muscle microvascular oxygenation ( <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\mathrm{t}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> ; near-infrared spectroscopy) and time to exhaustion. Leg muscle <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\mathrm{t}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> was also assessed during cuff occlusion protocols. SC2I decreased the plasma concentration of the stable PGI<sub>2</sub> metabolite 6-keto prostaglandin F<sub>1α</sub> (CON: 203 (54) pg/mL; SC2I: 108 (54) pg/mL; P = 0.002). There was no difference in exercise tolerance (CON: 278 (55) s; SC2I: 298 (75) s), arterial blood pressure, heart rate, pulmonary <math> <semantics> <msub><mover><mi>V</mi> <mo>̇</mo></mover> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${\\dot V_{{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> or leg muscle <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\mathrm{t}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> from rest to moderate or severe exercise between conditions (P > 0.05 for all). Moreover, there was no significant difference in <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\mathrm{t}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> during cuff occlusion protocols between conditions. Contrary to our hypothesis, these data indicate that COX-2 is not obligatory for the regulation of skeletal muscle microvascular oxygenation at rest or during moderate or severe intensity exercise, and therefore does not modulate exercise tolerance in healthy adults.</p>","PeriodicalId":12092,"journal":{"name":"Experimental Physiology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental Physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1113/EP092518","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The cyclooxygenase (COX) pathway regulates vascular tone and, therefore, local O2 delivery-utilization matching. The two main isoforms, COX-1 and COX-2, may promote opposing effects on contracting muscle O2 transport in health by inducing vasoconstriction and vasodilatation, respectively. Whether COX-2 and its main vasodilatory product (prostacyclin, PGI2) modulate microvascular O2 transport to skeletal muscle and thus exercise tolerance is unknown. We tested the hypothesis that acute selective COX-2 inhibition (SC2I) would impair cardiorespiratory and skeletal muscle microvascular responses from rest to exercise, thereby reducing exercise tolerance in healthy adults. Twelve individuals participated in a randomized, double-blind, crossover study to receive SC2I (200 mg celecoxib) or placebo (control, CON). Moderate and severe intensity cycling were performed with measurements of heart rate, arterial blood pressure, pulmonary oxygen uptake ( ), leg muscle microvascular oxygenation ( ; near-infrared spectroscopy) and time to exhaustion. Leg muscle was also assessed during cuff occlusion protocols. SC2I decreased the plasma concentration of the stable PGI2 metabolite 6-keto prostaglandin F1α (CON: 203 (54) pg/mL; SC2I: 108 (54) pg/mL; P = 0.002). There was no difference in exercise tolerance (CON: 278 (55) s; SC2I: 298 (75) s), arterial blood pressure, heart rate, pulmonary or leg muscle from rest to moderate or severe exercise between conditions (P > 0.05 for all). Moreover, there was no significant difference in during cuff occlusion protocols between conditions. Contrary to our hypothesis, these data indicate that COX-2 is not obligatory for the regulation of skeletal muscle microvascular oxygenation at rest or during moderate or severe intensity exercise, and therefore does not modulate exercise tolerance in healthy adults.
期刊介绍:
Experimental Physiology publishes research papers that report novel insights into homeostatic and adaptive responses in health, as well as those that further our understanding of pathophysiological mechanisms in disease. We encourage papers that embrace the journal’s orientation of translation and integration, including studies of the adaptive responses to exercise, acute and chronic environmental stressors, growth and aging, and diseases where integrative homeostatic mechanisms play a key role in the response to and evolution of the disease process. Examples of such diseases include hypertension, heart failure, hypoxic lung disease, endocrine and neurological disorders. We are also keen to publish research that has a translational aspect or clinical application. Comparative physiology work that can be applied to aid the understanding human physiology is also encouraged.
Manuscripts that report the use of bioinformatic, genomic, molecular, proteomic and cellular techniques to provide novel insights into integrative physiological and pathophysiological mechanisms are welcomed.